HSBC Holdings plc provides banking and financial services worldwide. The company operates through Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets segments. The Wealth and Personal Banking segment offers retail banking and wealth products, including current and savings accounts, mortgages and personal loans, credit and debit cards, and local and international payment services; and wealth management services comprising insurance and investment products, global asset management services, investment management, and private wealth solutions. This segment serves personal banking and high net worth individuals. The Commercial Banking segment provides credit and lending, treasury management, payment, cash management, commercial insurance, and investment services; commercial cards; international trade and receivables finance services; foreign exchange products; capital raising services on debt and equity markets; and advisory services. It serves small and medium sized enterprises, mid-market enterprises, and corporates. The Global Banking and Markets segment offers financing, advisory, and transaction services; and credit, rates, foreign exchange, equities, money markets, and securities services; and engages in principal investment activities. It serves government, corporate and institutional clients, and private investors. HSBC Holdings plc was founded in 1865 and is headquartered in London, the United Kingdom.

HSBC appears to be a large and well-established bank in terms of scale, but the current valuation already appears to reflect its strengths to a significant extent. The multiples paint a mixed picture: P/E of 27.97 and P/S of 7.17 are materially above the industry median, while P/B of 1.65 is also above average, which limits the potential for further upside without an acceleration in earnings. At the same time, P/FCF of 4.12 looks attractive and is notably below the industry median, supporting the case for solid free cash flow generation. The recent trend in P/E and P/B over the last few quarters has generally not deteriorated dramatically, but it also does not provide a convincing signal of clear undervaluation. Profitability remains a weak point: ROE of 5.89, ROA of 0.38, and ROI of 3.84 are below the industry median, while return on tangible equity of 9.37 also does not look strong for a bank of this scale. At the same time, net profit margin is very high, but for the financial sector this metric should be interpreted cautiously, since it is not always directly comparable with non-financial companies. Operating profit and operating margin look weak and volatile, which reduces confidence in the sustainability of current earnings quality. On the other hand, TTM net income of 6.94 billion and revenue of 10.45 billion remain substantial and generally support the fundamental base. The company’s balance sheet is large and liquid in absolute terms: cash on hand exceeds 1 trillion, assets are around 3.23 trillion, and equity is nearly 197 billion, indicating strong systemic resilience. However, the quick ratio is zero, the current ratio is below 1, and debt to capital is above the median, so liquidity and leverage do not justify an aggressive upward revision in valuation. Dividend yield has declined from higher levels seen last year to 0.57, which reduces the stock’s appeal for income investors. Overall, the fundamentals support a moderately cautious view: the business is large and financially stable, but the valuation no longer looks cheap, and profitability and the dividend profile are not strong enough to justify a meaningful increase in the target price.

HSBC Holdings, plc.

HSBC remains a large and resilient bank, but its high valuation, weak profitability, and declining dividend yield limit growth potential.

State Street Corporation STT has signed an initial agreement to acquire Santander CACEIS Latam Securities Services, a joint venture (JV) owned by Santander Group and CACEIS. This is part of the company’s effort to expand its investment servicing footprint across Latin America.
The JV oversees approximately $470 billion in assets under custody (“AUC”) and $225 billion in assets under administration (“AUA”) as of June 30, 2026. The transaction will strengthen State Street’s presence in Brazil, Mexico and Colombia by expanding its custody, foreign exchange, fund administration and other middle- and back-office services. This will enable the company to better serve both regional and global institutional investors.
The financial terms of the deal have not been revealed yet. It is expected to be closed sometime in 2027, subject to regulatory approvals, employee consultation processes and other customary closing conditions.
Following the completion, State Street plans to retain the JV’s experienced local workforce and continue operating through its existing market licenses and regulatory frameworks. The company expects the combination of its global servicing platform with the JV’s local expertise to strengthen its ability to support clients with cross-border investment needs while expanding access to fast-growing Latin American markets.
Our Take on State Street’s Global Expansion Strategy
The impending acquisition is in line with State Street’s strategy of expanding its global investment servicing franchise through targeted acquisitions. It will strengthen the company’s presence across Brazil, Mexico and Colombia, further broadening its footprint in Latin America’s largest institutional investment markets.
State Street also continues to expand through new investment servicing mandates and rising client assets. As of June 30, 2026, the company reported record assets under custody and/or administration (AUC/A) of $57.86 trillion and record assets under management (AUM) of $6.28 trillion. This reflects continued business wins, client inflows and favorable market conditions.
Additionally, STT remains focused on investing in technology and enhancing its end-to-end servicing capabilities to support long-term revenue growth.
Over the past month, shares of State Street have gained 7.6%, outperforming the industry's growth of 5.3%
Image Source: Zacks Investment Research
At present, STT sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Business Restructuring Steps Taken by Other Financial Firms
Last week, HSBC Holdings plc HSBC agreed to sell its Singapore life and health insurance business to Allianz SE for $2.09 billion.
The divestiture aligns with HSBC's broader simplification and restructuring strategy of streamlining operations, exiting non-core businesses, redeploying capital to higher-return opportunities, and strengthening its core wealth management and wholesale banking franchises across Asia.
Earlier this month, Northern Trust Corporation NTRS agreed to sell its guardianship services business to Wintrust Financial Corporation's subsidiary, Wintrust Private Trust Company.
The divestiture aligns with NTRS' broader strategy of strengthening its core wealth management, asset servicing, and asset management businesses while streamlining its portfolio and focusing investments on areas with stronger long-term growth potential.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

State Street to Expand Latam Presence With Santander CACEIS JV Buyout

Shares of HSBC Holdings HSBC have gained 2.2% since the announcement of the deal to divest its Singapore life and health insurance business to Germany-based Allianz SE for $2.09 billion last week. This marks another step in the bank’s ongoing strategy to streamline operations and sharpen its focus on its core wealth management and wholesale banking businesses in the Asia region.
The deal is expected to be completed in the first half of 2027, subject to consent from the Monetary Authority of Singapore. Upon completion, HSBC Bank (Singapore) and HSBC Life Singapore will enter into an exclusive 15-year bancassurance distribution agreement with Allianz. This will allow HSBC to continue offering the life and health insurance products to its retail banking and wealth management customers in Singapore.
This transaction is expected to generate a pre-tax gain of approximately $1.8 billion and increase its Common Equity Tier 1 (CET1) ratio by up to 15 basis points following the upstreaming of the distributable gain. HSBC will receive an upfront payment of $200 million from Allianz under the long-term distribution agreement, with additional variable consideration linked to performance.
The sale is a U-turn for HSBC. In 2022, it had acquired AXA Singapore to strengthen its insurance presence in the country. Nonetheless, this May, the company announced it was reviewing HSBC Life Singapore's insurance business, intending to focus on higher-growth operations.
Our Take on HSBC’s Asia Focus Strategy
The divestiture aligns with HSBC’s ongoing simplification and restructuring strategy, which focuses on streamlining its global operations, exiting non-core businesses, redeploying capital to higher-return opportunities, and strengthening its wealth management and wholesale banking franchises in Asia.
By adopting a capital-light bancassurance model in Singapore, the company will continue distributing insurance products without maintaining capital-intensive insurance manufacturing operations.
HSBC has narrowed its investment banking activities in the U.K., Europe and the United States while sharpening its focus on Asia and the Middle East. This year, the bank completed the privatization of Hang Seng Bank and divested its U.K. life insurance business, as well as its retail banking operations in South Africa and Sri Lanka.
HSBC also reclassified its Malta business as held for sale and agreed to sell its Indonesian retail banking business while strategic reviews of its retail operations in Australia, Turkey and Egypt remain underway.
Over the past three months, shares of HSBC have gained 16.4%, outperforming the industry's rally of 15.1%.
At present, HSBC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Similar Steps Taken by Other Financial Firms
In June, Deutsche Bank AG DB entered into a definitive agreement to sell its retail banking, affluent private banking and wealth management business in India to Kotak Mahindra Bank.
The divestiture aligns with DB's broader Global Hausbank strategy, announced in November 2025, which emphasizes simplifying operations, enabling disciplined capital allocation and concentrating investments in businesses with stronger scale and competitive advantages.
Earlier this month, Northern Trust Corporation NTRS agreed to sell its guardianship services business to Wintrust Financial Corporation's subsidiary, Wintrust Private Trust Company.
The divestiture aligns with NTRS' broader strategy of strengthening its core wealth management, asset servicing, and asset management businesses while streamlining its portfolio and focusing investments on areas with stronger long-term growth potential.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

HSBC to Divest Singapore Insurance Unit to Allianz for $2.09B

Key Points
HSBC initiated coverage of SpaceX on Friday with a Hold rating and a $115 price target, below the company's $135 IPO price.
The bank's valuation includes a 2x premium for Elon Musk's record of commercializing new technologies.
Shares closed Friday within pennies of the new target, roughly 50% under their post-IPO high.
SpaceX (NASDAQ: SPCX) got a new review from a major bank on Friday, and it wasn't the vote of confidence shareholders were hoping for. HSBC initiated coverage of the rocket and satellite company with a Hold rating and a $115 price target. That number sits below the $135 price at which SpaceX went public in June.
The market wasted no time making its own statement. Shares fell as much as 6% on Friday, dipping below the new target shortly after its publication, before closing at $115.07 -- seven cents above it.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
That makes SpaceX the rare stock that trades simultaneously below its IPO price, right at a major bank's days-old price target, and roughly 50% below the high of $225.64 it reached shortly after its debut.
What's most interesting about HSBC's math, though, is how generous it tried to be.
A premium for Musk, and still a Hold
HSBC built its valuation as a sum of the parts, adding up what it believes SpaceX's businesses are worth. Then it did something unusual. It applied a 2x premium to account for CEO Elon Musk's track record of commercializing disruptive technologies. In other words, the bank built a 2x innovation premium into its sum-of-the-parts math, on the theory that Musk has repeatedly built industries where none existed.
Even with that premium, the answer came back at $115, along with a conclusion that the price already reflects much of the company's long-term growth potential -- including continued expansion of Starlink, rising launch activity, and the development of its artificial intelligence initiatives. The bank did sketch a friendlier picture. Its most optimistic scenario, which assumes the Starship rocket becomes commercially viable starting in 2027 and launch capacity doubles, values the stock at $293 per share. But that's the ceiling case, not the expectation.
That's the detail I'd sit with. When a valuation grants the founder credit most models never grant, and still can't reach the IPO price, the exercise says as much about the price as it does about the company.
The disagreement is enormous
To be fair, HSBC is one voice, and a notably cautious one next to the rest of Wall Street. The average price target on SpaceX sits at about $237, more than twice the recent share price. Even more telling, individual targets range from $62 all the way to $800. A range that wide is less a forecast than an admission that nobody has figured out how to value this company yet. And HSBC's Hold rating, for what it's worth, implies the stock roughly treads water from here. The bank's caution is about the price, not the business.
The fundamentals explain the confusion. SpaceX's trailing-12-month revenue totals about $19 billion, and its 2025 revenue grew 33% -- remarkable growth for an industrial company. But the stock's market capitalization stands at about $1.5 trillion, which values the company at more than 75 times its sales. The business remains unprofitable, too, as it pours money into developing its Starship rocket. There are no earnings to check the valuation against yet, and there won't be for some time.
Hard evidence is finally coming, though. SpaceX is expected to report its first quarterly results as a public company on Aug. 4, giving investors their first standardized look at the company's finances since the IPO. The first wave of insider share lockups begins expiring shortly after the report. For a debate currently running on beliefs, that report is the first common set of facts both sides will have to reckon with -- and every model on Wall Street, HSBC's included, gets rebuilt on real quarterly disclosure from that day forward.
So, is the newly cheaper stock worth buying now that it has fallen to even a skeptic's target? I don't think the target itself should drive anyone's decision. HSBC's $115 is one bank's estimate, and the consensus near $237 is an average of guesses that disagree with one another by hundreds of dollars.
My takeaway is simply that SpaceX's current valuation continues to require a lot of imagination to justify. A major bank went looking for reasons to be generous with SpaceX, applied the biggest one it could justify, and still concluded the stock was worth less than its IPO price.
I'm not buying before the company's Aug. 4 numbers are released. Sure, a business compounding revenue at 33% deserves respect. But at a $1.5 trillion valuation, I want to see more momentum in its financials before paying up for this stock.
Should you buy stock in Space Exploration Technologies right now?
Before you buy stock in Space Exploration Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Space Exploration Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $377,990!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,269,518!*
Now, it’s worth noting Stock Advisor’s total average return is 896% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of July 26, 2026.
HSBC Holdings is an advertising partner of Motley Fool Money. Daniel Sparks and his clients do not have positions in any of the stocks mentioned. The Motley Fool recommends HSBC Holdings. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

HSBC Just Started Covering SpaceX With a $115 Price Target. The Stock Closed Friday at $115.07.

(RTTNews) - Mastercard Inc. (MA), the U.S. payments network, Thursday announced expansion of 'In Control' virtual card number platform with new security controls, embedded payments and a single API connection.
The payments company said the enhancements to its business-to-business payments platform were aimed at helping issuers, corporates and platforms manage virtual card programs with greater control and less integration work.
Mastercard said its virtual card ecosystem now spans issuers, direct platforms and corporates across 43 countries and 174 currencies. The company cited data from Kaiser Associates calling 'In Control' the industry-leading virtual card number platform.
The Company will be rolling out two new controls across the virtual card lifecycle. 'Issuer Enforced Controls' let issuers set spend limits, transaction caps and validity periods at card creation. 'Clearing Controls,' first introduced last year, is intended to let corporates and platforms block invalid transactions and manage payment timing beyond authorization.
Citigroup Inc. (C), the U.S. bank, is live with both controls and is expected to be the first issuer to roll them out globally later this year, Mastercard said.
The Company also expanded 'Commercial Connect API,' the market's only single API front door for virtual cards, according to Kaiser Associates.
New features include the ability to apply multiple control sets at the real card level and to combine virtual card creation and payment initiation in one step.
Mastercard said fraud rates on virtual cards were less than one-fifth of those on non-virtual cards, and even lower for cards issued through 'In Control.'
Since launching its embedded virtual card program in March 2025, Mastercard said dozens of partners in expense management, ERP, accounts payable, travel, hospitality, healthcare and e-commerce had joined. It cited a new integration with SAP SE (SAP), the German software company, and a mobile virtual card launch with HSBC Holdings Plc. (HSBA.L), the UK bank, in the UAE.
On the NYSE, shares of Mastercard are currently losing 0.86 percent, changing hands at $527.41.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Mastercard Adds Security Controls, Single API To Virtual Card Platform

Key Points
Recent research from Vanguard suggests that international stocks in developed markets could outperform U.S. stocks in the next 10 years.
The Vanguard International High Dividend Yield ETF holds more than 1,500 stocks and has delivered 10 years of 10.8% annualized returns.
The Vanguard International Dividend Appreciation ETF offers a more narrowly targeted portfolio that might be betting too heavily on just a few other countries.
Is America still the best place in the world for Americans to invest? Recent research from Vanguard suggests that international stocks might offer stronger opportunities in the next few years.
The company's 2026 economic and market outlook said that "ex-U.S. equities" -- international stocks not including the U.S. -- are expected to deliver 4.9% to 6.9% average annual returns for the next 10 years, while U.S. stocks are expected to deliver only 4% to 5% returns. Another Vanguard report in June predicted that some of the best long-term gains from the artificial intelligence (AI) boom might go not to AI stocks, but to "developed markets outside the U.S." as global companies use AI to improve their operations.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Although Vanguard's research doesn't recommend any specific stocks or exchange-traded funds (ETFs), if you agree with this forecast, buying international dividend stocks could be a good strategy. That's because international stocks that pay high dividend yields tend to come from developed markets such as Japan, Canada, and Western Europe.
The Vanguard International High Dividend Yield ETF (NASDAQ: VYMI) and the Vanguard International Dividend Appreciation ETF (NASDAQ: VIGI) are two Vanguard ETFs that offer exposure to international dividend stocks. Both hold portfolios that include the types of stocks that Vanguard research says might outperform in the next few years.
But in the past 10 years, the Vanguard International High Dividend Yield ETF has delivered a total return of 188.1%, strongly outperforming the other fund:
Let's look at these two Vanguard international ETFs and see which could be a better choice for your investment dollars.
Vanguard International High Dividend Yield ETF (VYMI): 1,578 stocks, 10 years of 11.2% annualized returns
The Vanguard International High Dividend Yield ETF has had a strong recent run of performance. At recent prices, it has delivered a total return of 24% in the past year, which has outperformed the S&P 500 index.
Over a longer-term time horizon, the fund's past performance is less strong, but still solid. This international ETF has delivered annualized total returns (by net asset value) of 22% for the past three years, 12.9% for the past five years, and 11.2% for the past 10 years. It charges a low expense ratio of 0.07%.
Could this fund be a good choice for the future? It holds a diversified portfolio of 1,578 global stocks. If you want developed market stocks, this fund can provide that exposure. Its portfolio consists of 43.7% European stocks, 23.8% Pacific region stocks, and only 22.8% emerging markets.
This ETF's top five countries included in the portfolio are Japan (11.5% of the fund), the United Kingdom (11%), Canada (8.9%), Switzerland (7.5%), and Australia (7.3%). The fund's top 10 stock holdings include international banks such as HSBC Holdings (NYSE: HSBC), pharmaceutical giants such as Roche Holding (OTC: RHHBY), energy major Shell (NYSE: SHEL), and Australian mining company BHP Group (NYSE: BHP).
If you're concerned that U.S. tech stocks have gotten overheated, this fund can put your money to work in different parts of the global economy. Companies like these tend to be well-established and financially strong, which enables them to return lots of cash to shareholders. This dividend ETF has delivered a trailing-12-month dividend yield of 3.68%, which is higher than many of the best dividend index funds. And this fund has a price-to-earnings (P/E) ratio of 14.02, which makes it look much cheaper than the S&P 500 index earnings multiple of 25.37.
Vanguard International Dividend Appreciation ETF (VIGI): 343 stocks, 10 years of 7.98% annualized returns
Another way to invest in international dividend stocks is to use the Vanguard International Dividend Appreciation ETF. This fund uses a different approach. Instead of more than 1,500 stocks, its portfolio holds only 343 stocks. This fund is even more focused on developed markets, with only 5.1% of its assets invested in emerging-market stocks. It charges the same low 0.07% expense ratio as the other Vanguard fund.
The Vanguard International Dividend Appreciation ETF has some of the same names as VYMI in its top 10 stock holdings. It owns international banks such as Royal Bank of Canada (NYSE: RY) and Mitsubishi UFJ Financial Group (NYSE: MUFG), pharma stocks such as Roche Holding and Novartis (NYSE: NVS), and German tech and industrial companies SAP (NYSE: SAP) and Schneider Electric (OTC: SBGSY).
However, this fund has not performed as well as the other Vanguard international ETF. The Vanguard International Dividend Appreciation ETF has delivered average annual returns of 8% in the past year, 10.8% in the past three years, 4.6% in the past five years, and 7.98% in the past 10 years. It has underperformed the S&P 500 in all those time frames.
This dividend ETF is also lagging the other fund's dividend yield, with a trailing-12-month yield of 2.13%. And the Vanguard International Dividend Appreciation ETF has a more expensive P/E ratio at 19.33.
One possible risk of this fund is that its portfolio is less diversified than the other Vanguard ETF. The Vanguard International Dividend Appreciation ETF has almost 80% of its portfolio invested in its top five markets:
Japan: 30.9% of the fund
Canada: 23%
Switzerland: 14.4%
Germany: 5.5%
United Kingdom: 5.6%
That's a rather highly concentrated bet on just a few countries. If any of those countries experiences an economic downturn or a weakening of its currency against the U.S. dollar, that could be bad news for American investors in this fund.
Why buy VYMI vs. VIGI
Recent Vanguard research says developed markets outside the U.S. could outperform in the next few years; both funds fit that strategy. And in case you're concerned about high valuations of tech companies, these international dividend stock ETFs tend to hold value stocks, not growth stocks. The companies represented in these funds are involved in different parts of the global economy that are less directly involved with the AI boom.
But the Vanguard International High Dividend Yield ETF is more diversified, its P/E ratio is lower, and it has a track record of paying a higher dividend yield in the past 12 months. I believe this fund is a better choice for most long-term investors who want exposure to high-yield dividend stocks outside the U.S. market.
Should you buy stock in Vanguard International High Dividend Yield ETF right now?
Before you buy stock in Vanguard International High Dividend Yield ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard International High Dividend Yield ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $410,833!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,208,693!*
Now, it’s worth noting Stock Advisor’s total average return is 917% — a market-crushing outperformance compared to 209% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of July 9, 2026.
HSBC Holdings is an advertising partner of Motley Fool Money. Ben Gran has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Schneider Electric. The Motley Fool recommends BHP Group, HSBC Holdings, Roche Holding AG, and SAP. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

VYMI vs. VIGI: Which International Dividend ETF Is Better?

For Immediate Release
Chicago, IL – July 7, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eli Lilly and Co. LLY, HSBC Holdings plc HSBC, Palantir Technologies Inc. PLTR and CBL & Associates Properties, Inc. CBL.
Here are highlights from Monday’s Analyst Blog:
Top Stock Reports for Eli Lilly, HSBC and Palantir
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co., HSBC Holdings plc and Palantir Technologies Inc., as well a micro-cap stock CBL & Associates Properties, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Today's Featured Research Reports
Eli Lilly’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+58.2% vs. +39.7%). Demand for the company’s popular GLP-1 drugs, Mounjaro and Zepbound, remains strong, making them the company’s key top-line drivers. Lilly’s other new drugs like Kisunla, Omvoh and Jaypirca are also contributing to top-line growth.
Eli Lilly is also making rapid progress in its pipeline with its new oral GLP-1 obesity pill, Foundayo, expected to be a commercial game-changer for Lilly. Lilly has aggressively expanded through M&A in 2026 across oncology, neuroscience, cardiovascular and other areas to diversify growth beyond GLP-1 therapies.
Declining sales of Trulicity, rising pricing pressure on some drugs and potential competition in the GLP-1 market are some top-line headwinds. Estimates have declined slightly ahead of Q2 results. Lilly has a positive record of earnings surprises in recent quarters.
(You can read the full research report on Eli Lilly here >>>)
Shares of HSBC have outperformed the Zacks Banks - Foreign industry over the past year (+69.1% vs. +43%). The company’s wealth momentum in Asia continues to benefit from higher customer activity, rising balances and net new money, while the completed Hang Seng Bank privatization and ongoing business divestitures, including the planned Indonesia business sale, will simplify operations and support medium-term efficiency.
Further, a robust capital position and global footprint are expected to support its financials. However, the company has guided for higher expected credit losses (ECL) this year because of overlays tied to Middle East events and absorption of an idiosyncratic fraud-related charge.
Moreover, operating expenses are expected to remain elevated as the company invests in technology and distribution capabilities. Revenue visibility will depend on volatile rates and activity.
(You can read the full research report on HSBC here >>>)
Palantir’s shares have declined -5.8% over the past year against the Zacks Internet - Software industry’s decline of -18%. The company’s AI strategy, driven by Foundry, Gotham, and AIP platforms, targets government and commercial sectors, enabling real-time insights and operational efficiency.
Notable defense projects, like Open DAGIR and AIP boot camps for commercial clients, boost customer acquisition. With $7.2 billion in cash, no debt, and S&P 500 inclusion, Palantir enjoys strong liquidity, growing revenues, and increased investor visibility.
Meanwhile, PLTR's reluctance to pay dividends is a red flag for dividend-seeking investors. Intense competition from tech giants and declining cost flexibility as the company scales are notable headwinds.
(You can read the full research report on Palantir here >>>)
Shares of CBL & Associates Properties have outperformed the Zacks REIT and Equity Trust - Retail industry over the past year (+119.3% vs. +28.3%). This microcap company with a market capitalization of $1.63 billion, is strengthening its investment case through stable operating trends, disciplined capital allocation and a focus on high-quality, market-dominant retail assets.
Capital recycling, refinancing and redevelopment initiatives are enhancing portfolio quality, improving financial flexibility and supporting sustainable cash flow growth, while a conservative dividend policy supports shareholder returns.
However, the investment thesis remains balanced by modest organic NOI growth, tenant turnover, limited renewal pricing power, redevelopment execution risks and continued asset-level stress within weaker properties. The valuation suggests investors are assigning limited value to CBL’s long-term cash flow improvement potential and portfolio optimization efforts, leaving scope for upside if management continues to execute and operating performance strengthens.
(You can read the full research report on CBL & Associates Properties here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The Zacks Analyst Blog Highlights Eli Lilly, HSBC, Palantir and CBL & Associates

Monday, July 6, 2026
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), HSBC Holdings plc (HSBC) and Palantir Technologies Inc. (PLTR), as well a micro-cap stock CBL & Associates Properties, Inc. (CBL). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Ahead of Wall Street
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
You can read today's AWS here >>> Pre-Markets Muted Ahead of (Expected) Quiet Week
Today's Featured Research Reports
Eli Lilly’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+58.2% vs. +39.7%). Demand for the company’s popular GLP-1 drugs, Mounjaro and Zepbound, remains strong, making them the company’s key top-line drivers. Lilly’s other new drugs like Kisunla, Omvoh and Jaypirca are also contributing to top-line growth.
Eli Lilly is also making rapid progress in its pipeline with its new oral GLP-1 obesity pill, Foundayo, expected to be a commercial game-changer for Lilly. Lilly has aggressively expanded through M&A in 2026 across oncology, neuroscience, cardiovascular and other areas to diversify growth beyond GLP-1 therapies.
Declining sales of Trulicity, rising pricing pressure on some drugs and potential competition in the GLP-1 market are some top-line headwinds. Estimates have declined slightly ahead of Q2 results. Lilly has a positive record of earnings surprises in recent quarters.
(You can read the full research report on Eli Lilly here >>>)
Shares of HSBC have outperformed the Zacks Banks - Foreign industry over the past year (+69.1% vs. +43%). The company’s wealth momentum in Asia continues to benefit from higher customer activity, rising balances and net new money, while the completed Hang Seng Bank privatization and ongoing business divestitures, including the planned Indonesia business sale, will simplify operations and support medium-term efficiency.
Further, a robust capital position and global footprint are expected to support its financials. However, the company has guided for higher expected credit losses (ECL) this year because of overlays tied to Middle East events and absorption of an idiosyncratic fraud-related charge.
Moreover, operating expenses are expected to remain elevated as the company invests in technology and distribution capabilities. Revenue visibility will depend on volatile rates and activity.
(You can read the full research report on HSBC here >>>)
Palantir’s shares have declined -5.8% over the past year against the Zacks Internet - Software industry’s decline of -18%. The company’s AI strategy, driven by Foundry, Gotham, and AIP platforms, targets government and commercial sectors, enabling real-time insights and operational efficiency.
Notable defense projects, like Open DAGIR and AIP boot camps for commercial clients, boost customer acquisition. With $7.2 billion in cash, no debt, and S&P 500 inclusion, Palantir enjoys strong liquidity, growing revenues, and increased investor visibility.
Meanwhile, PLTR's reluctance to pay dividends is a red flag for dividend-seeking investors. Intense competition from tech giants and declining cost flexibility as the company scales are notable headwinds.
(You can read the full research report on Palantir here >>>)
Shares of CBL & Associates Properties have outperformed the Zacks REIT and Equity Trust - Retail industry over the past year (+119.3% vs. +28.3%). This microcap company with a market capitalization of $1.63 billion, is strengthening its investment case through stable operating trends, disciplined capital allocation and a focus on high-quality, market-dominant retail assets.
Capital recycling, refinancing and redevelopment initiatives are enhancing portfolio quality, improving financial flexibility and supporting sustainable cash flow growth, while a conservative dividend policy supports shareholder returns.
However, the investment thesis remains balanced by modest organic NOI growth, tenant turnover, limited renewal pricing power, redevelopment execution risks and continued asset-level stress within weaker properties. The valuation suggests investors are assigning limited value to CBL’s long-term cash flow improvement potential and portfolio optimization efforts, leaving scope for upside if management continues to execute and operating performance strengthens.
(You can read the full research report on CBL & Associates Properties here >>>)
Other noteworthy reports we are featuring today include Enterprise Products Partners L.P. (EPD), Flex Ltd. (FLEX) and UDR, Inc. (UDR).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
Modular Sales Approach & AI strategy Strengthen Palantir (PLTR)
Featured Reports
Enterprise (EPD) Banks On $5.3B Permian, Export Growth Projects
Per the Zacks analyst, Enterprise is advancing its $5.3 billion growth portfolio through Permian gas processing and Gulf Coast export expansions, supporting volume growth and cash flows through 2027.
Diverse Portfolio and Capital Recycling Aids UDR Amid Elevated Supply
Per the Zacks analyst, UDR's diverse portfolio, capital recycling efforts and tech-driven efficiencies support growth. Ye, elevated supply in select markets and rising competition raise concerns.
Encompass Health (EHC) Strengthens Growth Through Expansion Efforts
Per the Zacks analyst, Encompass Health's expansion through de novo hospitals will drive patient volumes and profit levels. However, escalating expenses remain a concern for the company.
Data Center Demand & Clean Energy Expansion Aid AES Corporation (AES)
Per the Zacks analyst, AES is benefiting from increasing demand from data centers through PPAs. Its strategic shift toward clean energy and LNG expansion is expected to boost project pipelines.
Strategic Buyouts Aid Builders FirstSource (BLDR), Housing Woes Ail
Per the Zacks analyst, Builders FirstSource benefits from strategic acquisitions, digital initiatives, productivity savings and cost actions. However, housing market weakness remains a concern.
Solid Momentum in Hydraulics Segment Benefits Helios (HLIO)
Per the Zacks analyst, solid traction of Helios' Hydraulics segment, led by strength in the mobile end market and improved distributor inventory levels, will result in momentum to the company.
ANI Pharmaceuticals' (ANIP) Rare Disease Segment Fuels Top Line Growth
The Zacks Analyst believes that demand for ANI's lead product, Cortrophin Gel, is strong. Based on this encouraging uptake, the company has guided to more than $1 billion in total revenues in 2026.
New Upgrades
FLEX Gains from Expanding Data Center Platform & Acquisitions
Per the Zacks analyst, Flex continues to deepen its exposure to the data center market through its Cloud and Power Infrastructure segment. Also, synergies from acquisitions bode well.
Wayfair Gains Market Share as Margins Expand and Orders Grow
Per the Zacks analyst, Wayfair continues to gain market share in home furnishings with orders and active customers rising while margins expand and guidance points to continued growth.
United Natural Foods (UNFI) Gains on Natural Product Sales Growth
Per the Zacks analyst, United Natural Foods benefits from Natural product sales growth. Natural segment sales rose 4.4% in Q3, led by demand for organic and specialty products and strong execution.
New Downgrades
Volume Weakness, EV Cancellations to Pressure Strattec (STRT)
Per the Zacks analyst, lower production volumes and EV program cancellations are expected to hurt Strattec's fiscal Q4,26 revenue, while weaker fixed-cost absorption could keep margins under pressure.
MercadoLibre Faces Margin Pressure Amid LatAm Volatility
Per the Zacks analyst, MercadoLibre faces currency volatility and margin pressure in Latin America as fintech spreads narrow and subsidy led growth investments weigh on near term profitability.
Accounting Controls Reset Irk ICON (ICLR) Amid Tough Competition
The Zacks analyst is concerned about ICON's improperly adjusted clinical services revenue, which resulted in overstating revenue by $65M in 2023 and $93M in 2024. Tough competition adds to the worry.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HSBC Holdings plc (HSBC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Top Stock Reports for Eli Lilly, HSBC & Palantir

Key Points
The iShares Core MSCI EAFE ETF (IEFA) invests only in developed market stocks outside of the United States and Canada.
The Vanguard Total International Stock ETF (VXUS) offers more comprehensive global coverage across both developed and emerging markets.
Vanguard's more diversified approach is better for an all-in-one investment fund.
As core international stock ETFs go, the iShares Core MSCI EAFE ETF (NYSEMKT: IEFA) and the Vanguard Total International Stock ETF (NASDAQ: VXUS) are among the best. Both have expense ratios of less than 0.1%. Both hold thousands of stocks, making diversification a non-issue.
But they're not nearly the same. Their target markets are different. Their key holdings are different. Their sector exposures are different. Both can act as core international equity funds, but the reality of these ETFs is very simple: One is a complete international fund, and one is not.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
iShares Core MSCI EAFE ETF
IEFA tracks the MSCI EAFE IMI Index, which covers around 2,600 stocks from nearly two dozen developed markets outside the United States and Canada. Japan (26%) and the U.K. (14%) alone account for around 40% of the portfolio. Financials (23%), industrials (19%), and tech (12%) are the top three sector holdings.
But the key point is that the iShares Core MSCI EAFE ETF holds only developed-market stocks. That means you'd need to pair this fund with an emerging markets fund, such as the iShares Core MSCI Emerging Markets ETF, to cover the entire international equity market.
Top holdings of IEFA include:
ASML Holding: 2.8%
HSBC Holdings: 1.3%
Roche: 1.2%
AstraZeneca: 1.2%
Novartis: 1.1%
This fund is the choice if you want solely stocks from developed markets or if you're interested in pairing it with a second fund for total international exposure.
Vanguard Total International Stock ETF
VXUS tracks the FTSE Global All Cap ex-US Index, which holds around 8,700 stocks across both developed and emerging markets. Around 26% of the fund is in emerging markets, with the remainder in non-U.S. developed markets, including Canada. Japan (15%), Taiwan (9%), and the U.K. (8%) are the biggest country allocations. Financials (22%), tech (21%), and industrials (15%) are the top three sector holdings.
The biggest distinction, again, is that the Vanguard Total International Stock ETF invests in virtually all non-U.S. stocks worldwide. It's more comprehensive globally, which is reflected in the much smaller country weightings. The addition of emerging markets gives the tech sector a much larger weighting, especially in some of the larger artificial intelligence (AI) stocks of the moment.
Top holdings include:
Taiwan Semiconductor Manufacturing: 3.98%
Samsung: 2.19%
SK Hynix: 1.86%
ASML Holding: 1.39%
Tencent Holdings: 0.74%
This fund is the choice if you want total international stock coverage in a single ticker.
VXUS is a better choice than IEFA
From a simplicity standpoint, the Vanguard Total International Stock ETF is the better choice. Including both developed and emerging markets in a diversified equity portfolio is preferable, given that the latter category includes many of the big foreign tech companies driving the AI theme at the moment.
The iShares Core MSCI EAFE ETF is reasonable enough if you want to stick just with developed economies. But the diversified approach is the better one.
Should you buy stock in Vanguard Total International Stock ETF right now?
Before you buy stock in Vanguard Total International Stock ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard Total International Stock ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $400,101!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,212,683!*
Now, it’s worth noting Stock Advisor’s total average return is 911% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of July 2, 2026.
HSBC Holdings is an advertising partner of Motley Fool Money. David Dierking has positions in Vanguard Total International Stock ETF. The Motley Fool has positions in and recommends ASML, AstraZeneca Plc, Taiwan Semiconductor Manufacturing, and Tencent. The Motley Fool recommends HSBC Holdings and Roche Holding AG. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

IEFA vs. VXUS: Both Are Cheap. Both Are Broad. Here Is the Key Difference Long-Term Investors Need to Understand.

HSBC Holdings plc HSBC is reportedly in early-stage discussions with Emirates NBD over a potential sale of its Turkish banking operations, per a Bloomberg report, citing people familiar with the matter. While neither lender has confirmed the negotiations, the development aligns with HSBC’s ongoing strategy of streamlining its international footprint and concentrating resources on higher-growth core markets.
If completed, the transaction would represent another significant step in HSBC’s portfolio optimization efforts under CEO Georges Elhedery, who has prioritized simplifying the bank’s global operations while improving efficiency and capital allocation.
HSBC has steadily reduced its presence in Turkey over the past decade as challenging economic conditions, currency volatility, regulatory pressures and intense competition affected profitability.
Once operating more than 300 branches in the country, the bank now maintains a significantly smaller network.
A potential divestment would be consistent with HSBC’s broader restructuring program, following recent exits from businesses in markets such as Germany, South Africa and Malta, while reinforcing its strategic focus on the U.K., Asia and the Middle East.
How Can the Deal Benefit Emirates NBD?
For Emirates NBD, acquiring HSBC Turkey would strengthen an already established presence through DenizBank, which it acquired from Sberbank in 2019.
The combination could create a more diversified banking franchise, with DenizBank’s strengths in retail, SME and agricultural banking complementing HSBC Turkey’s capabilities in wholesale banking, trade finance and wealth management.
The transaction could modestly expand Emirates NBD’s Turkish asset base despite ongoing macroeconomic risks, including inflation and currency volatility.
Conclusion
Although any transaction would require regulatory approval and the negotiations are currently preliminary, a potential sale highlights HSBC’s continued commitment to optimizing its global portfolio while focusing investment on markets that offer stronger long-term growth prospects.
HSBC’s Price Performance & Zacks Rank
Over the past six months, HSBC shares have gained 18.2%, outperforming the industry’s 10.2% growth.
Image Source: Zacks Investment Research
Currently, HSBC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Divestitures & Acquisitions by Other Finance Firms
Last month, Invesco IVZ completed the transfer of its Canadian fund management business to CI Global Asset Management (CI GAM), marking the close of a deal that significantly reshapes the Canadian investment fund landscape.
The transaction, initially announced in January 2026, involved management agreements tied to Invesco’s Canadian fund lineup, which oversaw approximately C$27 billion in assets. Now, CI GAM has assumed management responsibilities for 98 mutual funds and exchange-traded funds that were previously operated by Invesco Canada.
KKR & Co. Inc. KKR completed the acquisition of Arctos Partners, a premier institutional investor in professional sports franchise stakes globally and a provider of asset management solutions for sponsors.
The buyout is part of KKR’s strategy to expand its alternative investment platform through sports investing, GP solutions and secondaries capabilities, while strengthening its sourcing and origination engine across private markets.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

HSBC Weighs Turkey Exit as Emirates NBD Explores Acquisition Deal

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Dimensional International Value ETF (Symbol: DFIV) where we have detected an approximate $297.3 million dollar inflow -- that's a 1.5% increase week over week in outstanding units (from 362,100,000 to 367,600,000). Among the largest underlying components of DFIV, in trading today Shell plc (Symbol: SHEL) is down about 0.5%, HSBC Holdings plc (Symbol: HSBC) is off about 1%, and Toronto Dominion Bank (Symbol: TD) is lower by about 0.2%. For a complete list of holdings, visit the DFIV Holdings page » The chart below shows the one year price performance of DFIV, versus its 200 day moving average:
Looking at the chart above, DFIV's low point in its 52 week range is $42.50 per share, with $56.315 as the 52 week high point — that compares with a last trade of $54.12. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ».
Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs.
Further DFIV Research:
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Indicator	TTM Median
P/E	27.97 13.42
Price/Sales	7.17 2.20
P/B	1.65 1.24
P/FCF	4.12 10.90

Indicator	TTM Median
ROE	5.89 10.93
ROA	0.38 1.25
ROI	3.84 7.66
Net Worth	325.76 1.04
Quick Ratio	0.00 1.37
Current Ratio	0.92 0.98

Indicator	TTM Median
Net Profit Margin	58.89 17.42
Operating Margin	0.00 24.33
Gross Margin	100.00 71.15
Return on tangible equity	9.37 12.73

Indicator	TTM Median
EPS	0.57 0.71
EPS Forecast	0.90 0.72
Revenue	10.45B 89.00M
Gross Profit	10.45B —
EBITDA	0.00 —

HSBC Holdings, plc.

Recent quarterly and TTM performance

Valuation

Debts

Efficiency

Other ratios

Revenue